| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 121.46B | 115.36B | 122.13B | 116.62B | 103.03B |
| Gross Profit | 30.26B | 27.13B | 27.72B | 28.07B | 24.50B |
| EBITDA | 11.48B | 10.81B | 12.44B | 12.78B | 10.47B |
| Net Income | 6.39B | 5.00B | 6.29B | 7.71B | 5.01B |
Balance Sheet | |||||
| Total Assets | 131.00B | 121.90B | 120.27B | 116.44B | 101.57B |
| Cash, Cash Equivalents and Short-Term Investments | 30.31B | 30.93B | 25.23B | 33.16B | 29.40B |
| Total Debt | 1.04B | 1.11B | 2.09B | 3.53B | 4.93B |
| Total Liabilities | 49.65B | 45.52B | 45.88B | 45.28B | 37.73B |
| Stockholders Equity | 71.92B | 67.63B | 65.80B | 63.05B | 56.28B |
Cash Flow | |||||
| Free Cash Flow | 2.81B | 12.18B | 3.09B | 7.94B | 2.30B |
| Operating Cash Flow | 6.42B | 13.54B | 5.70B | 9.26B | 3.25B |
| Investing Cash Flow | -4.00B | -2.91B | -2.41B | -6.65B | -1.97B |
| Financing Cash Flow | -3.01B | -4.94B | -6.20B | -3.85B | -4.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥71.09B | 3.15 | ― | 3.28% | 12.54% | 171.52% | |
76 Outperform | ¥154.38B | 14.81 | ― | 2.30% | 15.87% | 40.46% | |
75 Outperform | ¥144.08B | 9.34 | 11.52% | 2.76% | 4.91% | 48.93% | |
66 Neutral | ¥162.13B | 15.99 | 18.89% | 2.78% | 9.16% | 59.49% | |
65 Neutral | ¥30.24B | 10.75 | 10.34% | 4.82% | -2.83% | 5.48% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |